Elsevier

Metabolism

Volume 40, Issue 12, December 1991, Pages 1323-1326
Metabolism

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

https://doi.org/10.1016/0026-0495(91)90037-WGet rights and content

Abstract

The reduction in cardiovascular risk induced by hormone replacement therapy is only partly explained by changes in serum lipids and lipoproteins. As body composition and body fat distribution in particular are independent predictors of cardiovascular disease, we investigated the effect of postmenopausal hormone therapy on body composition parameters directly measured. Sixty-two early postmenopausal women were followed up for 2 years in a prospective, randomized, placebo-controlled study. We found that combined estrogen-progestogen therapy prevented the increase in abdominal fat after menopause (P < .05), and that this effect was independent of the effect on serum lipids and lipoproteins. The therapy reduced postmenopausal bone loss significantly (P < .001), whereas it did not have a statistically significant influence on total body fat mass or total lean body mass. The findings of the present study suggest that some of the protective impact of postmenopausal hormone therapy on cardiovascular disease may be explained by the effect on body composition, in particular abdominal fat.

References (31)

  • TL Bush et al.

    Cardiovascular mortality and concontraceptive use of estrogen in women: Results from the lipid research clinics program follow-up study

    Circulation

    (1987)
  • MJ Stampfer et al.

    A prospective study of postmenopausal estrogen therapy and coronary heart disease

    N Engl J Med

    (1985)
  • TL Bush et al.

    Noncontraceptive estrogen use and cardiovascular disease

    Epidemiol Rev

    (1985)
  • J Haarbo et al.

    Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits

    J Clin Invest

    (1991)
  • L Lapidus et al.

    Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden

    Br Med J

    (1984)
  • Cited by (425)

    • Perspectives on Prediabetes and Aging

      2023, Endocrinology and Metabolism Clinics of North America
    • Endocrine Disruption and Disorders of Energy Metabolism

      2021, Endocrine Disruption and Human Health
    • Sexually dimorphic metabolic responses to exposure of a high fat diet during pregnancy, lactation and early adulthood in Gipr<sup>-/-</sup> mice

      2020, Peptides
      Citation Excerpt :

      Estrogens seem to have beneficial effects on adipose tissue since female adipose tissue is less insulin resistant and less vulnerable to inflammation than male adipose tissue [33,34]. In contrast, post-menopausal females are at risk of increased abdominal adiposity and metabolic syndrome which is reversed by estrogen replacement therapy [35]. Animal studies have shown that the removal of ovaries (ovariectomy) in females increases body weight and adiposity [36].

    • Metabolic disorders: Sex and gender evidence in dyslipidemia, diabetes, and obesity

      2020, How Sex and Gender Impact Clinical Practice: an Evidence-Based Guide to Patient Care
    View all citing articles on Scopus

    Supported by a grant from Statens Sundhedsvidenskabelige Forskningsrd, Copenhagen, Denmark.

    View full text